The global aortic valve replacement device market size was estimated at USD 5.81 billion in 2017. It is expected to grow at a CAGR of 11.1% over the forecast period. Increasing prevalence of valvular diseases such as aortic stenosis and aortic reflux and increasing preference for minimally invasive surgery are one of the major trends driving the market growth. Initiatives undertaken by various government agencies to raise awareness of valve replacement surgery are also expected to drive market growth.
A full report of Aortic Valve Replacement Devices Market available at https://www.orionmarketreports.com/aortic-valve-replacement-devices-market/413/
Aortic Valve Replacement Devices Market Segmentations
By Surgery
• Open surgery
• Minimally invasive surgery
By Product
• Transcatheter aortic valve
• Sutureless valve
• Others
By End-user
• Hospitals
• Ambulatory surgery centers
• Others
Key Players
• Boston Scientific Corporation
• Medtronic
• Abbott Laboratories
• LivaNova PLC
• Edwards Lifesciences Corporation
• CryoLife
• Biotronik
• Colibri Heart Valve
• JenaValve
• TTK HealthCare
• Others
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
